TNF alpha inhibitors in children with rheumatic diseases in Switzerland; establishment of a database

被引：0
|
作者：
Bolt, I.
Saurenmann, T.
Berthet, G.
Bolz, D.
Hofer, M.
Kaiser, D.
Sauvain, M. J.
机构：
[1] Kinderklin, Kinderrheumatol Sprechstunden Med, Bern, Switzerland
[2] Kinderklin, Kinderrheumatol Sprechstunden Med, Zurich, Switzerland
[3] Kinderklin, Kinderrheumatol Sprechstunden Med, Aarau, Switzerland
[4] Kinderklin, Kinderrheumatol Sprechstunden Med, Basel, Switzerland
[5] Kinderklin, Kinderrheumatol Sprechstunden Med, Lausanne, Switzerland
[6] Kinderklin, Kinderrheumatol Sprechstunden Med, Luzern, Switzerland
来源：
SWISS MEDICAL WEEKLY | 2007年 / 137卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5
引用
下载
收藏
页码：5S / 5S
页数：1
相关论文
共 50 条
  • [1] Risks associated with use of TNF inhibitors in children with rheumatic diseases
    Marino, Achille
    Giani, Teresa
    Cimaz, Rolando
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2019, 15 (02) : 189 - 198
  • [2] Harms of TNF inhibitors in rheumatic diseases: a focused review of the literature
    Jain, Archana
    Singh, Jasvinder A.
    IMMUNOTHERAPY, 2013, 5 (03) : 265 - 299
  • [3] Update on Anti-TNF-Alpha Treatment in Rheumatic Diseases
    Massarotti, Marco
    Ferrara, Antonella
    Marasini, Bianca
    CURRENT DRUG THERAPY, 2006, 1 (03) : 311 - 318
  • [4] EXPRESSION OF TNF-RECEPTORS, TNF-ALPHA AND TNF-BETA IN RHEUMATIC DISEASES
    HEILIG, B
    PEZZUTTO, A
    FIEHN, C
    EGEN, O
    HUNSTEIN, W
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 145 - 145
  • [5] COMPARISON OF TNF-α INHIBITORS EFFICACY BETWEEN RHEUMATIC DISEASES AND INFLAMMATORY BOWEL DISEASES
    Nuriakhmetova, T.
    Abdulganieva, D.
    Valeeva, I. K.
    Shevnina, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1516 - 1516
  • [6] Infection Risk After Orthopaedic Surgery in Patients with Inflammatory Rheumatic Diseases, with Focus On Discontinuation of TNF-Alpha-Inhibitors
    Scherrer, Catrina B.
    Mannion, Anne A. F.
    Kyburz, Diego
    Vogt, Markus
    Kramers-de Quervain, Ines A.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S713 - S714
  • [7] TNF-ALPHA, IFN-GAMMA AND THE SOLUBLE TNF-RECEPTOR IN RHEUMATIC DISEASES
    WITZMANN, G
    STEINER, G
    STUDNICKABENKE, A
    PARTSCH, G
    SMOLEN, J
    ARTHRITIS AND RHEUMATISM, 1992, 35 (09): : S339 - S339
  • [8] TROUGH LEVELS OF TNF-A INHIBITORS AND THEIR IMMUNOGENICITY IN THE TREATMENT OF RHEUMATIC DISEASES AND INFLAMMATORY BOWEL DISEASES
    Nuriakhmetova, T.
    Valeeva, I. K.
    Shevnina, J.
    Abdulganieva, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1269 - 1270
  • [9] The effectiveness for prevention of tuberculosis in patients with inflammatory rheumatic diseases treated with TNF inhibitors
    Rybar, I
    Rozborilova, E.
    Zanova, E.
    Micekova, D.
    Sojovic, I
    Rovensky, J.
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2008, 109 (04): : 164 - 167
  • [10] Factors for starting biosimilar TNF inhibitors in patients with rheumatic diseases in the real world
    Sung, Yoon-Kyoung
    Jung, Sun-Young
    Kim, Hyoungyoung
    Choi, Seongmi
    Im, Seul Gi
    Lee, Yu Sang
    Jang, Eun Jin
    Cho, Soo-Kyung
    PLOS ONE, 2020, 15 (01):
12345